ZHYBF — Zhong Yuan Bio-Technology Holdings Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
- $0.00m
- $1.73m
- $2.28m
Annual balance sheet for Zhong Yuan Bio-Technology Holdings, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.068 | 0.222 | 0.123 | 0.278 | 0.145 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.16 | 0.531 | 0.53 | 0.354 | 1.47 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.53 | 2.44 | 2.08 | 1.04 | 2.03 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.304 | 1.02 | 0.77 | 0.528 | 0.58 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 2.28 | 3.46 | 2.85 | 2.13 | 3.17 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.629 | 0.761 | 0.836 | 2.21 | 2.48 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.8 | 1.96 | 1.91 | 2.83 | 3.37 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1.48 | 1.5 | 0.941 | -0.699 | -0.205 |
| Total Liabilities & Shareholders' Equity | 2.28 | 3.46 | 2.85 | 2.13 | 3.17 |
| Total Common Shares Outstanding |